✦ LIBER ✦

Meta-Analysis of Healing and Prevention of Digital Ulcers in Systemic Sclerosis

✍ Scribed by Tingey, Theresa ;Shu, Jenny ;Smuczek, Joseph ;Pope, Janet

Book ID: 120211355
Publisher: Wiley (John Wiley & Sons)
Year: 2013
Tongue: English
Weight: 711 KB
Volume: 65
Category: Article
ISSN: 2151-464X
DOI: 10.1002/acr.22018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Management of Raynaud's phenomenon and d

Management of Raynaud's phenomenon and digital ulcers in systemic sclerosis

✍ Vasileios Botzoris; Alexandros A. Drosos 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 344 KB

Connective tissue diseases: Treatment of

Connective tissue diseases: Treatment of digital ulcers in systemic sclerosis

✍ Lambova, Sevdalina; Müller-Ladner, Ulf 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 158 KB

Skin ulcers in systemic sclerosis: Deter

Skin ulcers in systemic sclerosis: Determinants of presence and predictive factors of healing

✍ Stefano Alivernini; Maria De Santis; Barbara Tolusso; Alice Mannocci; Silvia Lau 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 180 KB

Effects of bosentan on digital ulcers in

Effects of bosentan on digital ulcers in patients with systemic sclerosis

✍ Kawaguchi, Yasushi 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 96 KB

A pilot trial of treprostinil for the tr

A pilot trial of treprostinil for the treatment and prevention of digital ulcers in patients with systemic sclerosis

✍ Lorinda Chung; David Fiorentino 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 124 KB

Digital ulcers in systemic sclerosis: Pr

Digital ulcers in systemic sclerosis: Prevention by treatment with bosentan, an oral endothelin receptor antagonist

✍ J. H. Korn; M. Mayes; M. Matucci Cerinic; M. Rainisio; J. Pope; E. Hachulla; E. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 2 views

## Abstract ## Objective Recurrent digital ulcers are a manifestation of vascular disease in patients with systemic sclerosis (SSc; scleroderma) and lead to pain, impaired function, and tissue loss. We investigated whether treatment with the endothelin receptor antagonist, bosentan, decreased the